Immune T cell defence is coping with COVID-19 variants of concern – for now Description:Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impairedDate:01 December 2022 University of Birmingham signs up for strategic research vision in India Description:Our experts are working with partners in India on research and education collaborations that will help improve people's lives.Date:28 November 2022 World’s first clinical trial to test new drug glenzocimab for heart attacks Description:New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.Date:23 November 2022 ‘Playbook’ sets out ways to fight back against antimicrobial resistance Description:‘Resistance breakers’ and better genetic tests are among new ways that scientists could address antimicrobial resistance, a new paper suggests.Date:21 November 2022 Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship Description:Dr Jon Hazeldine, Research Fellow at the University of Birmingham, has been awarded a competitive MRC Career Development Award Fellowship totalling £1.2M.Date:16 November 2022 Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments Description:The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignanciesDate:15 November 2022 New UK-first trial to screen 20,000 children for type 1 diabetes Description:Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis Date:14 November 2022 Childhood maltreatment linked with higher risk of asthma and atopic disease Description:UK analysis raises need for awareness of health implications for patients following abuse and neglectDate:14 November 2022 Rare cancer treatment changed thanks to major clinical trial Description:Children and adult with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a CRCTU clinical trial.Date:11 November 2022 Antibody therapies against Covid-19 for most vulnerable patients work, new analysis finds Description:The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective.Date:08 November 2022 Rethinking mountain water security Description:Water security in mountain regions relies on an understanding of the interlinks of water supply and demand that goes far beyond the study of glacier melt.Date:07 November 2022 How chameleon cancers can change their colors to survive treatment Description:Some leukemias evade treatment by changing their appearance and identity through changing the read-out of their DNA, a new study has found. Date:27 October 2022 Previous12345678Next